BENEVICH ERIC (Chief Commercial Officer) sold 3.2% of their position (2.15K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $333.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2026ACC: 0001643653-26-000016
Officer· Chief Commercial Officer
Since Feb 2019
-2.15K
Net shares
Net seller
$333.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.19K acquired · 5.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.19K
Price / share
$43.24
Trade value
$138.11K
% of position
5.0%
9/9/2026
63.37K→66.56K
Common Stock
Direct
Shares
−2.15K
Price / share
$154.61
Trade value
$333.03K
% of position
3.2%
9/9/2026
66.56K→64.41K
Total
Net shares
+1.04K
Net value
-$194.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2026 | M · Option Exercise | +3.19K | $43.24 | $138.11K | 5.0% | 63.37K | 66.56K |
| Common Stock Direct | 9/9/2026 | S · Sale | −2.15K | $154.61 | $333.03K | 3.2% | 66.56K | 64.41K |
| Total | +1.04K | -$194.92K | ||||||
Derivative Transactions1
Incentive Stock Option
Direct
Converts to
Common Stock
3.19K shares
Shares
−3.19K
Strike price
43.24
Held after
0.00
Exercisable
—
9/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Incentive Stock Option Direct | Common Stock3.19K shares | 9/9/2026 | M · Option Exercise | −3.19K | 43.24 | — | 0.00 |